0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Role of Toll-like Receptor 4 Mutations in Gram-Negative Septic Shock—Reply

Jean Paul Mira, MD; David A. Schwartz, MD, MPH; Kathy L. Frees
Arch Intern Med. 2002;162(21):2496. doi:.
Text Size: A A A
Published online

Extract

In reply

We appreciate Dr Yende's interest in our article1 and the opportunity to respond to Dr Yende's concerns. It appears that Dr Yende is uneasy about 2 issues: (1) the use of a 1-sided statistical test and (2) the inclusion of only 73 patients for the control study group. Dr Yende states that "1-sided statistical tests should be limited to conditions in which overwhelming evidence suggests that the effect will occur only in 1 direction." Our decision to use a 1-sided statistical test was based on our specific hypothesis that the mutations of human TLR4 associated with hyporesponsiveness to inhaled endotoxin would also enhance the susceptibility of humans to gram-negative sepsis. This hypothesis is supported by our previous study that demonstrated that the mutations in human TLR4 under investigation in this study were associated with a decreased response to inhaled lipopolysaccharide,2 and studies in mice that have demonstrated that mice that contain mutations in TLR4 are both hyporesponsive to lipopolysaccharide3,4 and are more susceptible to gram-negative bacterial challenge.5 Thus, in our study under question,1 we were only investigating one side of the hypothesis that individuals with mutations of TLR4 would be more susceptible to gram-negative sepsis. The second concern raised by Dr Yende was also addressed in the article; the control population had been previously established by Dr Mira through the blood collection bank at the Cochin University Hospital (Paris, France) and, in part, was successfully used in a previous study.6 Moreover, the control population in the current study1 had the same prevalence of the lone Asp299Gly polymorphism as had been observed previously in an independently collected study population,2 providing further support for the representativeness of the control study group. Finally, while we believe that our findings are consistent with the biological and pathophysiological importance of TLR4, we recognize that our study is limited by the size of our study population and the generalizability of our findings. Given these limitations, we strongly endorse the need to have our hypothesis retested in an independently collected population.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

November 25, 2002
Jean Paul Mira, MD; David A. Schwartz, MD, MPH; Kathy L. Frees
Arch Intern Med. 2002;162(21):2496. doi:.
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();